MZTI Form 4: CFO Pigott buys 2,973 shares, sells 887 at $180.29
Thomas K. Pigott, Vice President, Chief Financial Officer and Assistant Secretary of The Marzetti Company (MZTI), reported insider transactions dated 08/21/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Thomas K. Pigott, Vice President, Chief Financial Officer and Assistant Secretary of The Marzetti Company (MZTI), reported insider transactions dated 08/21/2025. The Form 4 shows an acquisition of 2,973 shares (transaction code A) recorded at $0.0000, which increased beneficial ownership to 17,766 shares, followed by a disposition of 887 shares (transaction code F) at $180.29, leaving 16,879 shares beneficially owned after the transactions.
The filing was signed by Patricia S. Callahan as attorney-in-fact on 08/22/2025. All details in this summary are taken directly from the submitted Form 4 and reflect routine officer-level trading and a grant/acquisition event plus a sale.
Insights
TL;DR Routine insider activity: a small acquisition/grant and a partial sale, likely non-material to company valuation.
The Form 4 discloses a 2,973-share acquisition recorded at $0.00 and a 887-share sale at $180.29 by the CFO, leaving 16,879 shares held. The zero-dollar acquisition suggests a grant, option exercise with no incremental cash cost reported, or reporting convention rather than a market purchase; the sale size is modest relative to reported post-transaction holdings. There are no derivative transactions or additional disclosures that would indicate hedging, significant dilution, or material change in insider control. Overall, this transaction set appears routine and not materially impactful to MZTI's capital structure.
TL;DR Disclosure is standard and timely; transaction codes and signatures are properly recorded.
The reporting identifies the insider role (VP, CFO, Assistant Secretary), provides transaction dates and codes, and includes an attorney-in-fact signature with date. The presence of a zero-price acquisition alongside a paid disposition is common in periodic equity grant and planned sale activity. There is no indication of a Rule 10b5-1 plan checkbox or other contractual plan in the filing text provided. From a governance perspective, the Form 4 meets basic disclosure expectations but offers no additional material governance developments.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,973 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 887 | $180.29 | $160K |
AI-generated analysis. How Rhea-AI works. Not financial advice.